| COLL Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the COLL market cap history going back to 6/12/2015:
Also see: COLL Shares Outstanding History and COLL YTD Return |
COLL Market Cap History — Collegium Pharmaceuticals Capitalization Over Time
As of 4/30/2026 Collegium Pharmaceuticals has a market cap of 1.09 billion. Investors often follow the COLL market cap history to compare the size of the company over time.
This page shows COLL market capitalization trends over time, with 46 market cap datapoints presented, dating back to 6/12/2015.
| COLL Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
COLL Historical Market Cap: +9.77% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COLL Stock Price Chart |
| About Collegium Pharmaceutical Inc |
| Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. Co. commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta ER and Nucynta immediate-release (IR), Belbuca, and Symproic in the U.S.. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is a pain treatment option designed with abuse deterrent properties and uses a technology platform, DETERx. The Nucynta Products are ER and IR oral formulations of tapentadol. Nucynta ER is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic. We show 46 historical shares outstanding datapoints in our COLL shares outstanding history coverage, used to compute COLL market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing COLL market cap history over the course of time is important for investors interested in comparing COLL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of COLL versus a peer is one thing; comparing COLL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like COLL can fluctuate over the course of history. With this page we aim to empower investors researching COLL by allowing them to research the COLL market cap history. |
| COLL Current Stock Quote |
Quotes delayed 20 minutes  Free COLL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| COLL Share Performance |
| Market Cap Peers |
| Collegium Pharmaceuticals (COLL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
COM Market Cap History CON Market Cap History COO Market Cap History COOL Market Cap History COR Market Cap History CORI Market Cap History CORT Market Cap History COSM Market Cap History COT Market Cap History COYA Market Cap History More Healthcare companies » |
COLL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
